Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157)
Financial Results:
Cipla Ltd reported Revenues for Q2FY25 of ₹7,051.00 Crores up from ₹6,678.00 Crore year on year, a rise of 5.59%.
Total Expenses for Q2FY25 of ₹5,452.00 Crores up from ₹5,260.00 Crores year on year, a rise of 3.65%.
Consolidated Net Profit of ₹1,305.00 Crores up 12.99% from ₹1,155.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹16.13, up 15.13% from ₹14.01 in the same quarter of the previous year.